Related Experiment Video
Updated: Jun 7, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Bridge-therapy with enoxaparin in the preoperative period of endarterectomy
Jair Leopoldo Raso1, Rogério Zenóbio Darwich, Francisco de Lucca
1Instituto Mineiro de Neurocirurgia, Biocor Instituto, Belo Horizonte, MG, Brazil.
Insights
Bridge-therapy with enoxaparin effectively prevented stroke in patients undergoing endarterectomy, with a low risk of cervical clot formation. This low molecular weight heparin strategy is safe and recommended for such patients.
Area of Science:
- Vascular Surgery
- Cardiovascular Medicine
- Pharmacology
Background:
- Cervical clot is a potential complication following endarterectomy.
- Patients using aspirin or clopidogrel face increased risks.
- Interrupting antiplatelet therapy before surgery can lead to stroke.
Purpose of the Study:
- To evaluate the safety and efficacy of enoxaparin bridge-therapy.
- To assess the risk of stroke and cervical clot formation during therapy interruption.
Main Methods:
- Prospective study of 119 patients undergoing 124 endarterectomies.
- Aspirin or clopidogrel was discontinued and replaced with enoxaparin preoperatively.
- Patients were monitored for stroke and cervical clot complications.
Main Results:
- No strokes occurred during the enoxaparin bridge-therapy period.
- One patient (0.8%) developed a cervical clot postoperatively.
- The mortality rate was 0.8%, with no enoxaparin-related complications.
Conclusions:
- Bridge-therapy with enoxaparin is a safe and effective strategy for endarterectomy patients.
- Low molecular weight heparin can mitigate stroke risk while managing antiplatelet therapy.
- This approach minimizes perioperative complications in vascular surgery patients.
Abstract:
Cervical clot is one of the complications of endarterectomy. This risk may be higher in patients using aspirin or clopidogrel. On the other hand, stroke may occur if the medication is interrupted before surgery. We carried out a prospective study of 124 endarterectomies in 119 patients in which aspirin or clopidogrel was stopped and a bridge-therapy with enoxaparin was administered preoperatively. There was no case of stroke during the period of the bridge-therapy. One patient developed cervical clot (0.8%) in the fifth postoperative day. Mortality rate in this series was 0.8%. There was no complication directly related to the use of enoxaparin. Bridge-therapy with low molecular weight heparin is a safe strategy for patients elected for endarterectomy.
Related Concept Videos
Aneurysm IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
